Mahabadi Amir A, Lehmann N, Dykun I, Müller T, Kälsch H, Erbel R
Department of Cardiology, West-German Heart and Vascular Center, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Institute for Medical Informatics, Biometry, and Epidemiology, University of Duisburg-Essen, Essen, Germany.
Herz. 2015 Sep;40(6):863-8. doi: 10.1007/s00059-015-4342-z.
The presence and extent of coronary artery calcification (CAC) is established in primary prevention since the CAC score is the single best predictor of future cardiovascular events. While CAC progresses with increasing age, individual CAC progression can be estimated based on the subject's age, gender, and CAC percentile at first examination. To date, several algorithms and methods for the definition of CAC progression are available in the literature. Increased CAC progression is associated with traditional cardiovascular risk factors including hypertension, diabetes, and smoking status. Also, lipid-lowering therapy may influence the progression of CAC. Epicardial adipose tissue is a further cardiovascular risk marker that may lead to intensified CAC progression if its volume increases. In terms of clinical implications, initial data suggest that extensive CAC progression is linked to worse outcome; however, further studies are needed to establish this relationship and to define appropriate time intervals between repetitive examinations. This review article gives an overview of the existing literature with an emphasis on various definitions of CAC progression, predictors of increased CAC progression, as well as clinical implications.
冠状动脉钙化(CAC)的存在及程度在一级预防中已得到确认,因为CAC评分是未来心血管事件的最佳单一预测指标。虽然CAC会随着年龄增长而进展,但个体的CAC进展可根据受试者初次检查时的年龄、性别和CAC百分位数来估计。迄今为止,文献中已有多种定义CAC进展的算法和方法。CAC进展增加与包括高血压、糖尿病和吸烟状况在内的传统心血管危险因素相关。此外,降脂治疗可能会影响CAC的进展。心外膜脂肪组织是另一种心血管风险标志物,如果其体积增加,可能会导致CAC进展加剧。在临床意义方面,初步数据表明广泛的CAC进展与更差的预后相关;然而,需要进一步研究来确立这种关系,并确定重复检查之间的适当时间间隔。这篇综述文章概述了现有文献,重点介绍了CAC进展的各种定义、CAC进展增加的预测因素以及临床意义。